Learning from India? A new approach to secondary pharmaceutical patents

Shadlen, K. C.ORCID logo (2013). Learning from India? A new approach to secondary pharmaceutical patents.
Copy

LSE’s Kenneth Shadlen asks whether a recent Indian Supreme Court decision on pharmaceutical patents will make the country’s patent laws more effective, and how the decision may affect global access to affordable medicines.
Item Type Online resource
Copyright holders © 2013 The Author(s)
Departments LSE > Academic Departments > International Development
Date Deposited 28 Aug 2024
URI https://researchonline.lse.ac.uk/id/eprint/125235

Explore Further

picture_as_pdf
Download

Export as

EndNote BibTeX Reference Manager Refer Atom Dublin Core JSON Multiline CSV
Export

Downloads
View more statistics